Iron Bioavailability of Fortified Oat Drink
Launched by PEPSICO GLOBAL R&D · Aug 24, 2011
Trial Information
Current as of May 01, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 6 year old children (inclusive)
- • Normal BMI for age (WHO standard: 15.3-15.5 kg)
- • Apparently healthy, no metabolic or gastrointestinal disorder; non-anemic (Hemoglobin values not less than 11.5 mg/dL -WHO cut-off for respective age)
- • No medication or vitamin/mineral supplement will be consumed during the study; intake of vitamin/mineral supplement will be discontinued 2 weeks before the start of the study
- • Parents demonstrate an understanding of the given information and ability to comply with the study procedure
- • Obtained parental or legal representative's informed consent
- Exclusion Criteria:
- • Known gastrointestinal or metabolic disorder or experiencing blood losses over the past 6 months;
- • Children taking medication
- • Children who are anemic (Hemoglobin values less than 11.5 mg/dL - WHO cut-off value for this age)
- • Currently participating or having participated in another clinical trial during the past 3 months prior to the beginning of the study
About Pepsico Global R&D
PepsiCo Global R&D is a leading innovator in the food and beverage industry, dedicated to advancing the science of nutrition and product development. With a strong focus on health and wellness, the organization conducts rigorous clinical trials to explore the efficacy and safety of its products, aiming to enhance consumer experiences while promoting sustainable practices. Leveraging cutting-edge research methodologies and a multidisciplinary approach, PepsiCo Global R&D collaborates with academic institutions and healthcare professionals to drive evidence-based advancements in nutrition, ensuring that its offerings meet the evolving needs of consumers worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taguig City, , Philippines
Patients applied
Trial Officials
Trinidad P Trinidad, PhD
Principal Investigator
FNRI
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials